DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+5.65%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$136M
AUM Growth
+$136M
(+4.7%)
Cap. Flow
+$83.1K
Cap. Flow
% of AUM
0.06%
Top 10 Holdings %
Top 10 Hldgs %
53.89%
Holding
76
New
13
Increased
16
Reduced
15
Closed
10
Top Buys
| 1 |
Amgen
AMGN
|
$2.42M |
| 2 |
Biogen
BIIB
|
$1.36M |
| 3 |
Vir Biotechnology
VIR
|
$884K |
| 4 |
Alibaba
BABA
|
$623K |
| 5 |
Intel
INTC
|
$572K |
Top Sells
| 1 |
Bank of America
BAC
|
$2.92M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$2.04M |
| 3 |
Turning Point Brands
TPB
|
$1.8M |
| 4 |
Netflix
NFLX
|
$1M |
| 5 |
PayPal
PYPL
|
$499K |
Sector Composition
| 1 | Healthcare | 47.71% |
| 2 | Technology | 16.85% |
| 3 | Communication Services | 8.57% |
| 4 | Consumer Discretionary | 3.71% |
| 5 | Energy | 3.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$372B
| $11.5M | 7.02% | 72,000 | – | – |
|
2
argenx
ARGX
$43.6B
| $9.58M | 5.86% | 25,700 +700 | +3% | +$261K |
|
3
Micron Technology
MU
$133B
| $9.5M | 5.82% | 157,500 +2,500 | +2% | +$151K |
|
4
Regeneron Pharmaceuticals
REGN
$61.5B
| $9.06M | 5.55% | 11,025 +125 | +1% | +$103K |
|
5
Alphabet (Google) Class C
GOOG
$2.58T
| $8.42M | 5.16% | 81,000 -1,000 | -1% | -$104K |
|
|
ITCI
6
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.42M | 3.93% | 118,600 -37,650 | -24% | -$2.04M |
|
7
Xencor
XNCR
$580M
| $5.86M | 3.59% | 210,000 +4,027 | +2% | +$112K |
|
8
Energy Transfer Partners
ET
$60.8B
| $4.66M | 2.86% | 374,000 +6,500 | +2% | +$81.1K |
|
9
Prothena Corp
PRTA
$441M
| $4.08M | 2.5% | 84,250 +10,150 | +14% | +$492K |
|
10
Oracle
ORCL
$635B
| $4M | 2.45% | 43,000 | – | – |
|
|
11
Bank of America
BAC
$376B
| $3.95M | 2.42% | 138,000 -102,000 | -43% | -$2.92M |
|
12
SPDR Gold Trust
GLD
$107B
| $3.94M | 2.41% | 21,500 -2,500 | -10% | -$458K |
|
13
iShares Gold Trust
IAU
$50.6B
| $3.74M | 2.29% | 100,000 | – | – |
|
14
Incyte
INCY
$16.5B
| $3.07M | 1.88% | 42,500 -1,500 | -3% | -$108K |
|
15
Advanced Micro Devices
AMD
$264B
| $2.94M | 1.8% | 30,000 | – | – |
|
16
Eli Lilly
LLY
$657B
| $2.83M | 1.73% | 8,250 | – | – |
|
|
SGEN
17
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.46M | 1.51% | 12,150 -300 | -2% | -$60.7K |
|
18
AT&T
T
$209B
| $2.45M | 1.5% | 127,500 -15,000 | -11% | -$289K |
|
19
Apple
AAPL
$3.45T
| $2.43M | 1.49% | 14,750 | – | – |
|
|
20
Amgen
AMGN
$155B
| $2.42M | 1.48% | +10,000 | New | +$2.42M |
|
|
AOD
21
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $2.05M | 1.25% | 253,500 -18,500 | -7% | -$149K |
|
22
Nuveen Credit Strategies Income Fund
JQC
$754M
| $1.86M | 1.14% | 364,000 +52,580 | +17% | +$269K |
|
23
VanEck Junior Gold Miners ETF
GDXJ
$6.6B
| $1.78M | 1.09% | 45,000 | – | – |
|
|
24
Turning Point Brands
TPB
$1.79B
| – | – | -83,113 | Closed | -$1.8M |
|
25
Pfizer
PFE
$141B
| $1.64M | 1.01% | 40,250 +4,000 | +11% | +$163K |
|